The portfolio company has exclusive rights to the therapeutic use of Leukothera, which targets Leukocyte Function Antigen-1 (LFA-1) on white blood cells, through a license from the University of Medicine and Dentistry of New Jersey.

Randeep Wilkhu, senior investment manager at T-Venture, and Robert Dighero, angel investor and partner at Passion Capital, have joined Smarkets as board members.

Intel Capital, the corporate venturing unit of the eponymous US-listed chip maker, and NHN Investment, which provides the same role for the Korea-based eponymous media group, invested in Nexmo.

BrightBytes' platform, Clarity for Schools, provides data on the relationship between a school's use of technology and student achievement.

The other investors in the B round included Japan state and corporate-backed Innovation Network, Japan-based industrial group Hosiden and venture capital firm Clean Pacific Ventures.

China Fortune said a wholly-owned subsidiary acquired convertible bonds from Jolla in December and agreed to exercise its option to purchase 11,944 shares.

In December, SynapDx raised $6m in its series B round from venture capital firms North Bridge Venture Partners and General Catalyst Partners.

Venture capital firm Jungle Ventures, which is backed with Singapore government money, invested alongside Innov8.